| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | May 18, 2026 | Sale | $5.06 | 3,342 | 16,927 | 336,764 | May 20, 2026, 04:30 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Apr 06, 2026 | Sale | $5.69 | 55,000 | 313,137 | 340,106 | Apr 07, 2026, 04:55 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Mar 13, 2026 | Award/Grant | $2.64 | 2,623 | 6,935 | 395,106 | Mar 17, 2026, 09:22 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Feb 18, 2026 | Sale | $6.38 | 10,173 | 64,924 | 392,483 | Feb 20, 2026, 05:05 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Nov 18, 2025 | Sale | $9.27 | 1,127 | 10,447 | 240,991 | Nov 20, 2025, 05:21 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Oct 17, 2025 | Sale | $8.94 | 13,133 | 117,436 | 242,266 | Oct 17, 2025, 07:26 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Sep 12, 2025 | Award/Grant | $2.64 | 2,193 | 5,798 | 222,251 | Sep 16, 2025, 05:30 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Aug 18, 2025 | Sale | $4.67 | 1,115 | 5,205 | 220,058 | Sep 10, 2025, 04:59 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Aug 18, 2025 | Sale | $4.67 | 2,735 | 12,767 | 220,058 | Aug 20, 2025, 05:00 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | May 16, 2025 | Sale | $2.77 | 1,074 | 2,979 | 221,173 | May 20, 2025, 05:00 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Mar 14, 2025 | Award/Grant | $2.61 | 2,128 | 5,554 | 222,247 | Apr 01, 2025, 07:58 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Feb 19, 2025 | Sale | $4.41 | 4,326 | 19,091 | 220,119 | Feb 21, 2025, 05:10 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Dec 10, 2024 | Option/RSU Exercise | $2.33 | 2,500 | 5,825 | 123,195 | Dec 12, 2024, 05:00 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Dec 10, 2024 | Sale | $8.20 | 2,500 | 20,491 | 120,695 | Dec 12, 2024, 05:00 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Nov 11, 2024 | Sale | $7.82 | 2,500 | 19,557 | 120,695 | Nov 13, 2024, 05:33 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Nov 11, 2024 | Option/RSU Exercise | $2.33 | 2,500 | 5,825 | 123,195 | Nov 13, 2024, 05:33 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Oct 10, 2024 | Option/RSU Exercise | $2.33 | 5,000 | 11,650 | 125,695 | Oct 15, 2024, 01:45 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Oct 10, 2024 | Sale | $8.10 | 5,000 | 40,496 | 120,695 | Oct 15, 2024, 01:45 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Sep 10, 2024 | Option/RSU Exercise | $2.33 | 5,000 | 11,650 | 125,695 | Sep 11, 2024, 05:17 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Sep 10, 2024 | Sale | $10.65 | 5,000 | 53,274 | 120,695 | Sep 11, 2024, 05:17 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Aug 12, 2024 | Sale | $11.53 | 5,000 | 57,635 | 120,695 | Aug 13, 2024, 06:34 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Aug 12, 2024 | Option/RSU Exercise | $2.33 | 5,000 | 11,650 | 125,695 | Aug 13, 2024, 06:34 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Jul 10, 2024 | Option/RSU Exercise | $2.33 | 5,000 | 11,650 | 175,695 | Jul 12, 2024, 04:55 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Jul 10, 2024 | Sale | $16.50 | 26,969 | 444,979 | 152,073 | Jul 12, 2024, 04:55 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Jul 11, 2024 | Sale | $17.07 | 28,031 | 478,409 | 120,795 | Jul 12, 2024, 04:55 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Jun 10, 2024 | Sale | $17.65 | 5,000 | 88,264 | 172,733 | Jun 12, 2024, 05:00 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | Jun 10, 2024 | Option/RSU Exercise | $2.33 | 5,000 | 11,650 | 175,695 | Jun 12, 2024, 05:00 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | May 13, 2024 | Option/RSU Exercise | $2.33 | 5,000 | 11,650 | 175,695 | May 14, 2024, 04:04 PM | |
| LXEO | Lexeo Therapeutics, Inc. | Richard Nolan Townsend | Chief Executive Officer | May 13, 2024 | Sale | $13.22 | 5,000 | 66,093 | 170,695 | May 14, 2024, 04:04 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More